(1)
Karaman, O.; Kim, M.; Scurti, G.; Kraśko, J. A.; Bochnacka, O.; Quinn, S.; Pasukoniene, V.; Nishimura, M. I. CD19 Chimeric Antigen Receptor (CAR) Modified Cytokine Killer Cells Compared to Classical CD19 CAR-T: Advantages and Disadvantages. SEE J Immunol 2025, 8, 062.